BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16352422)

  • 21. Characterization of a novel plasmid-mediated cephalosporinase (CMY-9) and its genetic environment in an Escherichia coli clinical isolate.
    Doi Y; Shibata N; Shibayama K; Kamachi K; Kurokawa H; Yokoyama K; Yagi T; Arakawa Y
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2427-34. PubMed ID: 12121914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CMY-13, a novel inducible cephalosporinase encoded by an Escherichia coli plasmid.
    Miriagou V; Tzouvelekis LS; Villa L; Lebessi E; Vatopoulos AC; Carattoli A; Tzelepi E
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3172-4. PubMed ID: 15273143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression of high-level cephalosporinase due to mutation in the AmpC attenuator of a clinical Escherichia coli strain].
    Guan XZ; Liu YN; Luo YP; She DY; Lu SJ; Zhou G; Chen LA
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):600-4. PubMed ID: 16681904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence of Escherichia coli isolates producing conjugative plasmid-mediated DHA-1 beta-lactamase in a Korean university hospital.
    Song W; Kim JS; Kim HS; Jeong SH; Yong D; Lee KM
    J Hosp Infect; 2006 Aug; 63(4):459-64. PubMed ID: 16772105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-level cefepime resistance in Escherichia coli from Singapore producing OXA-1 beta-lactamase.
    Koh TH; Wang G; Koh TY
    Int J Antimicrob Agents; 2008 Apr; 31(4):382-3. PubMed ID: 18178066
    [No Abstract]   [Full Text] [Related]  

  • 26. Characterisation of CTX-M and AmpC genes in human isolates of Escherichia coli identified between 1995 and 2003 in England and Wales.
    Hopkins KL; Batchelor MJ; Liebana E; Deheer-Graham AP; Threlfall EJ
    Int J Antimicrob Agents; 2006 Sep; 28(3):180-92. PubMed ID: 16879949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasmid-mediated quinolone resistance determinants among enterobacterial isolates from outpatients in Brazil.
    Minarini LA; Poirel L; Cattoir V; Darini AL; Nordmann P
    J Antimicrob Chemother; 2008 Sep; 62(3):474-8. PubMed ID: 18552340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CTX-M-15-producing multidrug-resistant enteroaggregative Escherichia coli in the United Arab Emirates.
    Sonnevend A; Al Dhaheri K; Mag T; Herpay M; Kolodziejek J; Nowotny N; Usmani A; Sheikh FA; Pál T
    Clin Microbiol Infect; 2006 Jun; 12(6):582-5. PubMed ID: 16700710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasmid-mediated quinolone resistance and β-lactamases in Escherichia coli from healthy animals from Nigeria.
    Fortini D; Fashae K; García-Fernández A; Villa L; Carattoli A
    J Antimicrob Chemother; 2011 Jun; 66(6):1269-72. PubMed ID: 21393162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid dissemination and diversity of CTX-M extended-spectrum beta-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America.
    Pallecchi L; Bartoloni A; Fiorelli C; Mantella A; Di Maggio T; Gamboa H; Gotuzzo E; Kronvall G; Paradisi F; Rossolini GM
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2720-5. PubMed ID: 17548490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence of imipenem resistance in clinical Escherichia coli during therapy.
    Oteo J; Delgado-Iribarren A; Vega D; Bautista V; Rodríguez MC; Velasco M; Saavedra JM; Pérez-Vázquez M; García-Cobos S; Martínez-Martínez L; Campos J
    Int J Antimicrob Agents; 2008 Dec; 32(6):534-7. PubMed ID: 18775649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
    Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of CTX-M-15, CTX-M-22, and SHV-2 extended-spectrum beta-lactamases (ESBLs) in Escherichia coli fecal-sample isolates from pig farms in China.
    Tian GB; Wang HN; Zou LK; Tang JN; Zhao YW; Ye MY; Tang JY; Zhang Y; Zhang AY; Yang X; Xu CW; Fu YJ
    Foodborne Pathog Dis; 2009 Apr; 6(3):297-304. PubMed ID: 19272004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmid-encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli.
    Papagiannitsis CC; Tzouvelekis LS; Tzelepi E; Miriagou V
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3763-7. PubMed ID: 17664321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of extended-spectrum beta-lactamase and class 1 integron integrase gene intl1 in Escherichia coli from Thai patients and healthy adults.
    Pongpech P; Naenna P; Taipobsakul Y; Tribuddharat C; Srifuengfung S
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):425-33. PubMed ID: 18564681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of TEM-, SHV- and AmpC-type beta-lactamases from cephalosporin-resistant Enterobacteriaceae isolated from swine.
    Rayamajhi N; Kang SG; Lee DY; Kang ML; Lee SI; Park KY; Lee HS; Yoo HS
    Int J Food Microbiol; 2008 May; 124(2):183-7. PubMed ID: 18455821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel bla(CTX-M-14) gene-harboring complex class 1 integron with an In4-like backbone structure from a clinical isolate of Escherichia coli.
    Bae IK; Lee YH; Jeong HJ; Hong SG; Lee SH; Jeong SH
    Diagn Microbiol Infect Dis; 2008 Nov; 62(3):340-2. PubMed ID: 18703304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Most Escherichia coli strains overproducing chromosomal AmpC beta-lactamase belong to phylogenetic group A.
    Corvec S; Prodhomme A; Giraudeau C; Dauvergne S; Reynaud A; Caroff N
    J Antimicrob Chemother; 2007 Oct; 60(4):872-6. PubMed ID: 17660264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of resistance and mobility among multidrug-resistant CTX-M-producing Escherichia coli from Canadian intensive care units: the 1st report of QepA in North America.
    Baudry PJ; Nichol K; DeCorby M; Lagacé-Wiens P; Olivier E; Boyd D; Mulvey MR; Hoban DJ; Zhanel GG
    Diagn Microbiol Infect Dis; 2009 Mar; 63(3):319-26. PubMed ID: 19216943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
    J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.